| Q37403748 | An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation |
| Q27011610 | Anaphylactic reaction to platelet transfusion as the initial symptom of an undiagnosed systemic mastocytosis: a case report and review of the literature |
| Q55374006 | Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers. |
| Q34192100 | Anaphylaxis: mechanisms and management |
| Q42292311 | CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells |
| Q33427338 | Early recognition is the key to success: pulseless electrical activity (PEA) as a manifestation of heparin-induced anaphylactoid reaction |
| Q37734315 | Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells |
| Q30438074 | Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design. |
| Q90614167 | FcεRI-HDAC3-MCP1 Signaling Axis Promotes Passive Anaphylaxis Mediated by Cellular Interactions |
| Q30458593 | Food-induced anaphylaxis. |
| Q90357108 | Function of secreted phospholipase A2 group-X in asthma and allergic disease |
| Q33831022 | Genomic responses during acute human anaphylaxis are characterized by upregulation of innate inflammatory gene networks |
| Q36505809 | IgE-Mediated Anaphylaxis to Foods, Venom, and Drugs: Influence of Serum Angiotensin Converting Enzyme Levels and Genotype |
| Q28276574 | Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets |
| Q89937684 | Mas-related G protein coupled receptor-X2: A potential new target for modulating mast cell-mediated allergic and inflammatory diseases |
| Q24296488 | Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization |
| Q64899299 | Mast Cells and Their Progenitors in Allergic Asthma. |
| Q28510556 | Mast cell maturation is driven via a group III phospholipase A2-prostaglandin D2-DP1 receptor paracrine axis |
| Q27687421 | Mast cell modulation of the vascular and lymphatic endothelium |
| Q35014406 | Mast cell stabilization alleviates acute lung injury after orthotopic autologous liver transplantation in rats by downregulating inflammation |
| Q83029950 | Mast cells and inflammation |
| Q38633155 | Mast cells in asthma--state of the art. |
| Q42030753 | Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis |
| Q37956534 | Mediators released during human anaphylaxis |
| Q47800446 | Neuro-immune interactions in allergic diseases: novel targets for therapeutics |
| Q60301536 | Neutrophil oxidative burst as a diagnostic indicator of IgG-mediated anaphylaxis |
| Q93016483 | Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications |
| Q44098562 | Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation |
| Q90613314 | Platelets trigger perivascular mast cell degranulation to cause inflammatory responses and tissue injury |
| Q36539857 | Potential effector and immunoregulatory functions of mast cells in mucosal immunity |
| Q34986991 | Recognition and management of food-induced anaphylaxis |
| Q35377560 | RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock. |
| Q28079028 | Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases |
| Q37821491 | Rupatadine for the treatment of allergic rhinitis and urticaria |
| Q36240870 | Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function |
| Q47810222 | The pathophysiology of anaphylaxis |
| Q28544768 | Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin |
| Q37156655 | Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer |
| Q64944377 | Unique Lipid Signatures of Extracellular Vesicles from the Airways of Asthmatics. |
| Q38285821 | Update on rupatadine in the management of allergic disorders |
| Q47151536 | Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1. |
| Q37798030 | What's new in asthma pathophysiology and immunopathology? |
| Q38375846 | n-3 Polyunsaturated fatty acids and mast cell activation |
| Q36951709 | β-Defensins activate human mast cells via Mas-related gene X2. |